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Chronic Paracetamol Treatment Influences Indices of 
Reactive Oxygen Species Accumulation in the 
Aging Fischer 344 X Brown Norway Rat Aorta 
Kevin M. Rice 1, Sarath Meduru 1, Sunil K Kakarla2, Anjaiah Katta2, Sri ram P. Mupparaju 1, Brent Kidd1, 
Lynne J. Goebel3, and Eric R. Blough 1· 4 
1 Center for Diagnostic Nanosystems, Marshall University, Huntington WV; 2 Department of Pharmacology, Physiology 
and Toxicology, Joan C. Edwards School of Medicine, Marshall University, Huntington WV; 3 Department oflnternal 
Medicine and Geriatrics, Joan C. Edwards School of Medicine, Marshall University, Huntington WV; 4 Department of 
Pharmaceutical Science and Research, School of Pharmacy, Marshall University, Huntington, WV 
Abstract. Previous reports have demonstrated that increased levels of reactive oxygen species (ROS) and 
alterations in cell signaling characterize aging in the Fischer 344 X Brown Norway (FBN) rat aorta. Other 
work has suggested that increases in ROS may be related to vascular wall thickening and the development 
of hypertension. Paracetamol (acetaminophen) is a potent antioxidant that has been found to diminish 
free radicals in ischemia-reperfusion studies. However, it remains unclear whether chronic paracetamol 
administration influences signaling or ROS accumulation in the aging aorta. FBN rats (27 months old; 
n=8) were subjected to 6 months of treatment with a therapeutic dose of paracetamol (30 mg/kg/day) and 
compared to age-matched untreated FBN rat controls (n=8). Compared to measurements in the aortae of 
6-month old animals, tunica media thickness, tissue superoxide levels, and protein oxidation levels were 
38 ± 7%, 92 ± 31 o/o, and 7 ± 2% higher in the aortae of 33-month control animals (p <:;,0. 05). Chronic 
paracetamol treatment decreased tunica media thickness and the amount of oxidized protein by 13 ± 4% 
and 30 ± 1 o/o, respectively (p <:;,0. 05). This finding of diminished aortic thickening was associated with in-
creased phosphorylation (activation) of the mitogen activated protein kinases and diminished levels of the 
anti-apoptotic protein Bcl-2. Taken together, these data suggest that chronic paracetamol treatment may 
decrease the deleterious effects of aging in the FBN rat aorta 
Keywords: aging; aorta; paracetamol; ROS; cell signaling 
Introduction 
It is estimated that by the year 2035, nearly one in 
four individuals will be 65 years of age or older [1]. 
Since cardiovascular diseases -such as coronary ar-
tery disease, peripheral vascular disease, hyperten-
sion, and chronic heart failure - are more prevalent 
among older persons, understanding why aging 
may be associated with increased incidence of car-
diovascular disease will perforce take on greater 
significance [1]. An emerging hypothesis, described 
as the free radical theory of aging, suggests that 
Address correspondence to Eric Blough; Center for Diagnostic 
Nanosystems; Room 241N, Robert C. Byrd Biotechnology Science 
Center Building; Department of Pharmaceutical Science and Research; 
1700 3rd Ave. Marshall University; Huntington, WV 25755-1090; 
e-mail: blough@marshall.edu 
aging occurs through the gradual accumulation of 
free radical damage to biomolecules [2]. Inherent 
to this theory is that oxidative stress (often mea-
sured by alterations in levels of serum protein C, 
TNF-alpha and other cytokines) increases with ad-
vancing age. It is thought that oxidative stress both 
promotes and is induced by vascular disease and 
risk factors that lead to vascular disease. 
Paracetamol (acetaminophen) is one of the most 
widely used of all drugs, with a wealth of experi-
ence clearly establishing it as the standard anti-
pyretic and analgesic for mild to moderate pain. 
Recent ischemia-reperfusion work has suggested 
that paracetamol exhibits antioxidant properties 
that may be cardia-protective and anti-arrhythmic 
under conditions of increased oxidative stress [3]. 
0091-7370/12/0200-152. © 2012 by the Association of Clinical Scientists, Inc. 
Whether paracetamol might offer protection 
against the effects of age-associated increases in 
vascular oxidative stress is currently unclear. 
Previous work by our laboratory has reported that 
aging in the Fischer 344 X Brown Norway (FBN) 
rat aorta is characterized by increased levels of reac-
tive oxygen species (ROS) and alterations in the 
regulation of the stress-activated signaling mole-
cule adenosine monophosphate-activated protein 
kinase (AMPK), the apoptotic regulators Bax and 
Bcl-2, and the mitogen-activated protein kinases 
(MAPK) [4]. These data are important given that 
these molecules and pathways may be involved in 
regulating vascular smooth muscle growth, which 
can give rise to increases in vessel thickness and 
blood pressure if allowed to proceed unregulated. 
Additional studies have demonstrated that the 
function and activity of specific MAPKs such as 
p38 kinase, extracellular-signal-regulated kinase 
1/2 (ERK 1/2-p44/p42), as well as the c-Jun 
N-terminal kinase (JNK), have been found to be 
regulated by ROS in vascular tissues [5-7]. While 
other research has demonstrated that paracetamol 
is involved in the regulation of the MAPKs and 
apoptosis in hepatocytes [8-10], how paracetamol 
may regulate these molecules in the aging aorta 
has, to our knowledge, not yet been investigated. 
Therefore, the purpose of this study was to deter-
mine how aging and paracetamol treatment alter 
the production of ROS and markers of oxidative 
stress in the aging FBN rat aorta. We hypothesized 
that chronic treatment with therapeutic doses of 
paracetamol would result in a diminished age-asso-
ciated increase in aortic ROS and activation of 
stress-activated signaling. 
Materials and Methods 
Animals. All procedures were performed in accor-
dance with the Marshall University Institutional 
Animal Care and Use Committee (IACUC) guide-
lines, using the criteria outlined by the American 
Association of Laboratory Animal Care (AALAC) 
as set forth in the Animal Welfare Act (PL89-544, 
PL91-979, and PL94-279). Fischer 344/NNiaHSD 
x Brown Norway/BiNia (FBN) rats aged 6 and 27 
months, were purchased from the National 
Institute on Aging colony at Harlan. Animals were 
housed two per cage m an AALAC 
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approved vivarium with a 12 hour light-dark cycle 
and a temperature maintained at 22 ± 2°C, and fed 
ad libitum. All animals were allowed to acclimatize 
for two weeks before initiation of any treatment or 
procedures. All animals were examined for precipi-
tous weight loss, failure to thrive, or unexpected 
gait alterations, and animals with apparent abnor-
malities or tumors were removed from the study. 
Periodic weight measurements were taken through-
out the duration of the study. 
Materials. Acetaminophen tablets or pure com-
pound used in the study was provided by McNeil 
Pharmaceuticals (Fort Washington, PA). 
Antibodies against Bax, Bcl-2, and mouse lgG, 
goat lgG, and rabbit lgG antibodies were pur-
chased from Santa Cruz Biotechnology, Inc. (Santa 
Cruz, CA). Antibodies against AMPK-a, 
p44/42(ERK1/2-MAPK), p38-MAPK, SAPK/ 
JNK- MAPK, p-AMPK-a (Thr 172), p-p44/42 (Thr 
202/Try 204), p-p38 (Thr 180/Try 182), p-SAPK/JNK 
(Thr 183/Tyr 185), biotinylated protein ladder, and 
mouse and rabbit lgG antibodies were purchased 
from Cell Signaling Technology (Beverly, MA). 
Precast 10% SDS-PAGE gels were procured from 
Cambrex Biosciences (Baltimore, MD). Enhanced 
chemiluminescence (ECL) western blot detection 
reagent was acquired from Amersham Biosciences 
(Piscataway, NJ). Restore western blot stripping 
buffer was obtained from Pierce (Rockford, IL), 
and 3T3 cell lysates were from Santa Cruz 
Biotechnology (Santa Cruz, CA). All other chemi-
cals were purchased from Sigma (StLouis, MO). 
Chronic paracetamol treatment. 27-month old 
FBN rats (n=8) were subjected to 6 months- thus, 
up to the age of 33 months - of treatment with 30 
mg/kg/day of acetaminophen administered 
through drinking water. Age-matched FBN con-
trol animals (n=8) were maintained under the same 
environmental conditions without any drug 
treatment. 
Aortic specimen collection. Rats were anesthe-
tized with a ketamine-xylazine (4:1) cocktail (50 
mg/kg IP) and supplemented as necessary for re-
flexive response. In a sterile environment, the ven-
tral surface of the thorax was shaved and the super-
ficial musculature was exposed by means of a 
transverse incision through the skin distal to the 
154 Annals of Clinical & Laboratory Science, vol. 42, no. 2, 2012 
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hematoxylin and eosin, mounted, 
and cover-slipped. Morphometric 
evaluation was performed with the 
use of a computerized imaging analy-
sis system (Image J). Medial thick-
ness in micrometers was calculated 
from the average of eight different 
points of cross section. H ydroethidine 
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(HE), an oxidative fluorescent dye, 
was used to visualize superoxide pro-
duction in situ [11, 12]. HE is perme-
able to cells and in the presence of 
superoxide ( 0 2 · -) is oxidized to 
Ethidium bromide, where it interca-
lates unable DNA [13]. Because 
Ethidium is unable to cross the cell 
membranes, extracellular 0 2 · 
would not be expected to significant-
ly contribute to the observed cellular 
fluorescence [14]. Since neither hy-
droxyl radical, 'NO, peroxynitrite, 
H 20 2, hypochlorite, nor singlet 0 2 
6mon 33mon con 33monAPAP significantly oxidizes HE, an increase 
in Et fluorescence is thought to spe-
cifically indicate 0 2 . - generation 
within the fluorescing cell. Briefly, 
aortic sections were incubated for 30 
min at 37"C with 5mM HE. After 
extensive washing with PBS and 
mounting (permount), tissue was vi-
Figure I. Aortic medial thickness is altered with aging and 
paracetamol treatment in F344/N X BN rat. The mediar thickness 
of aortae from 6-month and 33-month old control and 33-month 
paracetamol-treated rats. Data are presented as means ± SE. Insets: 
rep~esentative H & E stained aortic sections. (*) indicates significant 
diHerence from adult (6-month old) value (P<0.05). (t) indicates sig-
nificant difference from the 33-month old control value (P<0.05). n = 
8 for all groups. Scale Bar = 50 11m. 
thoracic cavity. After midline laparotomy and per-
foration of the heart, the aorta was isolated and re-
moved from its origin at the left ventricle to the 
renal arch and placed in Krebs-Ringer bicarbonate 
buffer (KRB) containing 118mM NaCl, 4.7mM 
KC1, 2.5mM CaC12, 1.2mM KH2PO 4, 1.2mM 
MgS04, 24.2mM NaHC03 and 10mM a-D-glu-
cose, (pH 7.4) equilibrated with 5% C02 I 95o/o 0 2 
and maintained at 37"C. Isolated aortae were 
cleaned of connective tissue, weighed and immedi-
ately snap frozen in liquid nitrogen. 
Histology and oxidative fluorescent microscopy. 
Aortic specimens were serially sectioned (8 11m) us-
ing an IEC Microtome cryostat and collected on 
poly-lysine coated slides. After fixing in acetone 
(22aC for 2 min), sections were stained with 
sualized under fluorescence using an 
Olympus fluorescence microscope 
(Melville, NY) and analyzed using imaging soft-
ware (AlphaEaseFC). The intensity of fluorescent 
Et-stained nuclei was calculated by digitizing im-
ages and then determining the average pixel inten-
sity of six randomly positioned regions (1000 mm2) 
per arterial cross section. Six images per vessel were 
analyzed with :e:500 nuclei per vessel examined. 
Immunoblot analysis. Tissues were pulverized in 
liquid nitrogen using a mortar and pestle until a 
fine powder was obtained. After washing with ice-
cold PBS, pellets were lysed on ice for 15 minutes in 
T-PER (2mL/1g tissue weight) (Pierce, Rockford, 
IL) and centrifuged for 10 minutes at 2000 X g to 
pellet particulate matter. Protein concentrations of 
homogenates were determined in triplicate via the 
Bradford method (Pierce), using bovine serum 
albumin as a standard. Samples were 
diluted to a concentration of 2.0flg/ 
f.!l in SDS loading buffer and boiled 
for 5 min. 40 flg of total protein per 
sample was separated on a 10% 
SDSPAGE gel. Transfer of protein 
onto nitrocellulose membranes was 
performed using standard condi-
tions [15]. To verify transfer of pro-
teins and equal loading of lanes, the 
membranes were stained with 
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For immunodetection, membranes 
were blocked in 5% Milk TBST for 
1 h at room temperature and then 
incubated with the appropriate pri-
mary antibody overnight. After 
washing in TBST, the membranes 
were exposed to horseradish peroxi-
dase-labeled IgG (HRP) secondary 
antibody for 1 h. Protein bands were 
visualized with ECL (Amersham 
Biosciences). Exposure time was ad-
justed to keep the integrated optical 
densities (IODs) within a linear and 
non-saturated range. Band signal in-
tensity was quantified by densitom-
etry using a flatbed scanner (Epson 
Pefection 3200 PHOTO) and imag-
ing software (AlphaEaseFC). 
Molecular weight markers (cell sig-
naling) were used as molecular mass 
standards, and NIH 3T3 celllysates 
were included as positive controls. A 
Figure 2. Alterations in ROS with aging and paracetamol treat-
ment in F344/N X BN rat aortae. Detection of vascular superoxide 
by dihydroethidium (hydroethidine) with aging in the aortae of 
6-month and 33-month old control and 33-montb old paracetamol-
treated F344/N X BN rats. The increase in su_peroxide involves all 
L_1yers within the ve~sel wall.. Scale. Bar= 50f1m. Quantification of aor-
tlc ROS as determmed by mtens1ty of fluorescent Et-stained nuclei. 
~esults are expressed as percent of the 6-month integrated optical den-
slty (100) value. An asterisk (*) indicates significant difference from 
the 6-month old control value (P<0.05), (t) indicates significant differ-
ence from the 33-month old control value (P<0.05). n = 8 for all 
groups. 
total of three SDS-PAGE gels were run for each 
experimental set to evaluate changes in dependent 
variable tissue content and basal phosphorylation 
where applicable. lmmunoblots were stripped with 
restore western blot stripping buffer as described by 
the manufacturer to obtain direct comparisons be-
tween expression and phosphorylation levels of dif-
ferent signaling molecules. After verifying the ab-
sence of residual HRP activity by treating the 
membrane with the ECL reagent, membranes were 
washed and re-probed with HRP labeled antibody. 
To minimize potential experimental error associ-
ated with membrane stripping, the order of anti-
body incubation was randomized between 
experiments. 
OxyBlotTM Analysis. OxyBlot analysis was per-
formed, according to manufacturer's specifications 
(Millipore, Billerica, MA), to identify carbonyl 
groups that are introduced into the amino acid side 
chain after oxidative modification of proteins. The 
level of protein oxidation was determined by an 
Oxidized Protein Detection Kit (OxyBlot, 
Chemicon Cat# 57150-Kit). The OxyBlot kit de-
rivatizes carbonyl groups to a 2, 4-dinitrophenyl-
hydrazone (DNP) moiety. The DNP moiety can 
then be detected using anti-DNP antibodies and is 
a method to assay for one form of oxidative damage 
to a protein. The proteins were derivatized as per 
the protocol given in the kit. These proteins were 
separated on 10% SDS-PAGE gels and transferred 
156 Annals of Clinical & Laboratory Science, vol. 42, no. 2, 2012 
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Figure 3. Alterations in Protein oxidation with aging and 
paracetamol treatment in F344/N X BN rat aortae. Protein iso-
1ates from the aortae excised from 6-month old and 33-month old 
control and 33-month old paracetamol-treated F344/N X BN rats 
were analyzed by immunob1ottin_g_for changes in protein oxidation. 
Data are presented as means ± SE. Insets: representative blots for 
protein oxidation. An asterisk (*) indicates significant difference 
From the 6-month old control value, p < 0.05, (t) indicates s~gnifi­
cant difference from the 33-month ofd control value (P<O. 05). n = 
8 for all groups. 
membranes were washed in washing 
buffer (TBS with 0.2% Tween-20). 
Protein bands were visualized with ECL 
(Amersham Biosciences). Band signal 
intensity was quantified by densitometry 
using a flatbed scanner (Epson Pefection 
3200 PHOTO) and imaging software 
(AlphaEaseFC). 
Statistical Methods. Results are pre-
sented as mean ± SEM. Statistical anal-
yses were performed using Sigma Plot 
11.2 statistical software. Comparisons 
between morphologic indices and pro-
tein expression were evaluated by One 
Way Analysis ofVariance (ANOVA) fol-
lowed by a Student-Newman-Keuls 
post-hoc analysis. The level of signifi-
cance accepted a priori was~ 0.05. 
Results 
Aging is associated with increased 
aortic wall thickness and evidence of 
increased ROS. The tunica media 
thickness in aortae from the 33-month 
old control animals was 38 ± 7% higher 
than that of the 6-month old control 
animals (p~0.05) (Figure 1). Ethidium 
(Et) fluorescence was seen throughout 
the aortic cross section with prominent 
signal in both the endothelial and me-
dial portions (Figure 2). Compared to 
levels in the 6-month old control ani-
mals, superoxide levels, as determined 
by the oxidation of HE to Et and the 
quantification of Et fluorescence, were 
91 ± 31% higher in the aortae of 
onto nitrocellulose membranes. After the transfer, 
membranes were blocked with 2.5% BSA (in Tris 
Buffered Saline [TBS] with 0.2% Tween-20) for 1 
h at room temperature. The nitrocellulose mem-
brane was exposed to a primary rabbit anti-DNPH 
protein antibody from Chemicon Oxyblot (1:200 
working dilution) for 1 h, and then to a secondary 
antibody [Goat Anti-Rabbit IgG (HRP-
conjugated)] diluted in the blocking solution 1:500 
for 1 h at room temperature. After every step, 
33-month control animals (p ~ 0. 05) (Figure 2). 
Similarly, protein oxidation as determined by the 
OxyBlot assay was 7 ± 2% higher in the 33-month 
old control animals (p ~0.05) (Figure 3). 
To determine whether aging influenced the total 
amount of AMPK-a present in the aorta, gel elec-
trophoresis and immunoblot analysis using anti-
bodies that recognize both the unphosphorylated 
and phosphorylated forms of AMPK-a were per-
formed. There were no differences between 6- and 
33-month old control aortae in the total content of 
AMPK- a (data not shown). Compared to levels in 
the 6-month old control animals, the basal phos-
phorylation levels of AMPK- a were 11 ± 6% lower 
in the 33-month old control animals (p ~ 0. 05) 
(Figure 4). 
Aging is associated with changes in MAPK sig-
naling and diminished expression of the apop-
totic regulator Bax. The MAPK proteins play an 
important role in propagating external stimuli into 
the cytoplasm and nucleus. The p38-MAPK con-
tent was 19 ± 7% less in the 33-month old control 
aortae than in the aortae from the 6-month old 
animals (p < 0.05) (Figure 5). No change in the 
total level of the p44 (ERK 1) - MAPK was ob-
served with aging. However, the amount of p42 
(ERK 2) - MAPK was 11 ± 3% lower in the 
33-month old control aortae than in the 6- month 
old control aortae (p ~0.05) (Figure 5). The JNK-1 
MAPK levels in the 33- month old control aortae 
were 19 ± 9% less than those found in the 6-month 
old control aortae (p ~ 0. 05) (Figure 5), while JNK-
2 MAPK levels were 29 ± 5% lower in the 33-month 
old control aortae compared to the 6-month old 
control aortae. The JNK-3 MAPK levels in the 
33-month old control aortae were not significantly 
different from levels in the 6- month old control 
aortae (Figure 5). 
The phosphorylated p38- MAPK content in the 
33-month old control aortae was 43 ± 12% less 
than that observed in the 6-month old control aor-
tae (p ~ 0. 05) (Figure 6). The activated levels of p44 
(ERK 1) - MAPK and p42 (ERK 2) - MAPK in the 
33-month old control aortae were 21 ± 3% and 
26 ± 2% lower than those in the 6-month old con-
trol aortae, respectively (p ~0.05) (Figure 6). The 
phosphorylated levels of JNK- 1 and JNK- 3 
MAPKs were 25 ± 5% and 22 ± 3% less than that 
found in 6-month old control animals (p ~ 0. 05) 
(Figure 6). 
With aging, the level of Bax expression decreased 
by 28 ± 9% in the 33-month old control aortae 
compared to in the 6-month old control aortae (p 
~0.05) (Figure 7). Bcl-2 levels were not altered 
with aging. 
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Figure 4. Aging and paracetamol treatment alters 
pliosphorylation status of signalingproteinAMPK a 
in F344/N X BN rat aortae. Protein isolates from the 
aortae excised from 6-month old and 33-month old 
control and 33-month old paracetamol-treated F344/N 
X BN rats were analyzed by immunoblotting for chang-
es in phosphorylated AMPK a. Data are presented as 
means ± SE. Insets: representative blots for phosphory-
lated AMPK a. An asterisk (*) indicates significant dif-
ference from the 6-month old control value, p < 0.05, 
(t) indicates significant difference from the 33-month 
old control value (P<O. 05). n = 8 for all groups. 
Paracetamol treatment decreases age-associated 
aortic thickening and protein oxidation. The tu-
nica media thickness in the paracetamol-treated 
aortae was 12 ± 4% less than that of the aortae 
from the 33-month old control animals (p~0.05) 
(Figure 1). No significant differences in the levels 
of 0 2 · - were found between the 33-month old 
control aortae and the paracetamol-treated aortae 
(Figure 2). The levels of oxidized proteins as deter-
mined by OxyBlot assay were 30 ± 1 o/o less in the 
33- month paracetamol aortae (p ~0.05) (Figure 
3). 
Paracetamol treatment alters AMPK-a, p44-
p42 (ERK 1/2}-, p38-, and ]NK-MAPK signal-
ing. There were no differences in the total content 
of AMPK- a between the 33-month old control 
and the 33- month old paracetamol-treated aortae 
(data not shown). Compared to the levels of the 33-
month old control aortae, the basal phosphoryla-
tion levels of AMPK- a were 20 ± 6% more in the 
33-month old paracetamol-treated aortae (p ~0.05) 
158 Annals of Clinical & Laboratory Science, vol. 42, no. 2, 2012 
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F!gure 5. Aging and paracetamol treatment di.fferen-
ttally affects the concentration ofproteins involved 
in aortic signaling. Protein isolates from the aortae ex-
cised from 6-montb old and 33-month old control and 
33-month old paracetamol-treated F344/N X BN rats 
were analyzed by immunoblotting for changes in total 
p44/p42 (ERK 1/2), p38 and Jnk protein expression. 
Data are presented as means ± SE. insets: re2resentative 
blots for total p44/p42 (ERK 1/2), p38 and Jnk. An as-
terisk (*) indicates significant difference from the 
6-month old control va1ue, p < 0.05, (t) indicates sig-
nificant difference from the 33-month old control value 
(P<0.05). n = 8 for all groups. 
(Figure 4). The p38- MAPK content in the 
33-month old paracetamol-treated aortae was 
24 ± 8% more than that seen in the aortae from the 
33-month old control animals (p <:;,0.05) (Figure 
5). The p44 and p42- MAPK levels are 20 ± 7% 
and 18 ± 2% lower in the 33-month old paracetamol-
treated aortae than in the 33-month old control 
aortae, respectively (p <:;, 0. 05) (Figure 5). There was 
no significant difference in the expression of total 
JNK-1 MAPK levels between the 33-month old 
control and the 33-month old paracetamol-treated 
aortae (Figure 5). The JNK-2 MAPK levels in 
paracetamol treated aortae were 22 ± 4% higher 
than in the 33-month old control aortae (p <:;,0.05). 
The JNK-3 MAPK levels in paracetamol-treated 
aortae were 14 ± 4% higher than in the 33-month 
old control aortae (p <:;, 0. 05) (Figure 5). 
The phosphorylated p38- MAPK content in the 
33-month old paracetamol-treated aortae was not 
significantly different than that in the 33-month 
old control aortae (Figure 6). The activated levels 
of p44 (ERK 1) - MAPK and p42 (ERK 2) - MAPK 
were 26 ± 2% and 15 ± 2% higher with treatment, 
respectively (p <:;,0.05) (Figure 6). Compared to 
the levels in the 33-month old control animals, the 
phosphorylated levels of JNK- 1 and JNK- 3 
MAPKs were 16 ± 6% and 41 ± 3% higher in the 
paracetamol-treated aortae (p <:;, 0. 05) (Figure 6). 
Paracetamol treatment alters the regulation of 
Bcl-2 but not Bax. The level of Bcl-2 protein was 
decreased by 13 ± 4% in the 33-month old 
paracetamol-treated animals compared to the 
33-month old controls (p <:;,0.05) (Figure 7). Bax 
levels were not altered with paracetamol 
treatment. 
Discussion 
Previous work from our lab has suggested that ag-
ing is associated with increased levels of oxidative 
stress [ 4]. Here we investigate if chronic paracetamol 
treatment affects the regulation of previously iden-
tified indices of oxidative stress in the aging FBN 
rat aorta. Our findings suggest that chronic treat-
ment with a therapeutic dose of paracetamol alters 
aortic morphology and the level of aortic oxidative 
stress. 
Alterations in aortic tunica media thickness and 
ROS. Our results concur with previous studies 
that showed an increase in tunica media thickness 
associated with advancing age [16, 17]. It has been 
generally accepted that increases in vascular ROS 
are linked to vascular smooth muscle cellular 
(VSMC) proliferation and hypertrophy [18-23], 
and therefore may act as a hypertrophic/hyperplas-
tic effector to thicken the arterial wall. This possi-
bility is important as increases in wall thickness are 
often associated with increased vessel stiffness, a 
primary risk factor for the development of hyper-
tension [24, 25]. Herein, we observed that 
paracetamol treatment appears to significantly de-
crease age-related increases in aortic wall thickness 
(Figure 1). Whether this decrease in aortic wall 
thickening with paracetamol is due to diminished 
VSMC hypertrophy or replication is currently 
unclear. 
In the present study we used dihydroethidium 
(HE) staining of the aortic cross sections to exam-
ine the efficacy of paracetamol treatment in attenu-
ating aortic ROS levels [26]. Our data suggest that 
aging in FBN rat aortae is characterized by a 
marked elevation in the level of superoxide anion 
(02 · -) and that the amount of superoxide anion 
elevation is unaltered with paracetamol treatment 
(Figure 2). In addition to superoxide levels, other 
ROS indices include the level of protein oxidation. 
Because of its highly diffusible nature across phos-
pholipid membranes [27], peroxynitrite is known 
to initiate oxidative modification of proteins. In 
our present study, protein oxidation in the rat aor-
tae (as determined by OxyBloC analysis) was 
found to be elevated with age, a finding consistent 
with previously reported data [28]. The elevation 
in the protein oxidation was decreased with 
paracetamol treatment (Figure 3). Although we 
suspect that decreases in protein oxidation with 
paracetamol treatment can be attributed to the an-
tioxidant properties of the paracetamol molecule, 
why paracetamol decreases protein oxidation levels 
but not the amount of superoxide remains unclear. 
Alterations in AMPK activity with age and 
paracetamol treatment. AMP-activated protein 
kinase (AMPK) is a stress-activated protein kinase 
that functions as a metabolic sensor of cellular ATP 
levels. Several investigators have shown that AMPK 
is also a redox-sensitive enzyme [29, 30]. AMPK is 
thought to be activated by phosphorylation when 
the ratio of ATP: ADP falls. Once activated, 
AMPK switches on catabolic pathways that gener-
ate ATP while switching off ATP-consuming pro-
cesses such as protein synthesis [31]. Our data sug-
gest that aging is associated with a decrease in 
AMPK-a (Thr 172) phosphorylation. The decrease 
in AMPK-a (Thr 172) phosphorylation we show 
with aging is similar to the change in AMPK phos-
phorylation one would expect to see in cells under-
going hypertrophy [32]. With paracetamol treat-
ment, the level of AMPK-a (Thr 172) 
phosphorylation appears to increase (Figure 4). 
This increase in the phosphorylation of AMPK-a 
(Thr 172) would be expected to decrease protein 
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Figure 6. Aging and paracetamol treatment alters 
pliosphorylation status of signalin_g proteins p38, 
p44!p42 (ERK 112)- MAPK-, and ]nk- MAPK in 
F34J/N X BN rat aortae. Protein isolates from the aor-
tae excised from 6-month old and 33-month old control 
and 33-month old paracetamol-treated F344/N X BN 
rats were analyzed by immunoblotting for changes in 
phosphorylated p38, p44/p42 (ERK 1/2), and ]nK pro-
tein expression. Data are presented as means ± SE. 
Insets: representative blots for phosphorylated p38. An 
asterisk (*) indicates significant difference from the 
6-month old control value, p < 0.05, (t) indicates sig-
nificant difference from the 33-month old control value 
(P<0.05). n = 8 for all groups. 
synthesis and may have contributed, at least in 
part, to the diminished aortic wall thickening we 
see with paracetamol treatment. 
Alterations in the regulation of MAPK and the 
Bax I Bcl-2 ratio with acetaminophen treat-
ment. The mitogen-activated protein kinase 
(MAPK) family has been shown to be activated by 
exogenous H 20 2 and by endogenously-generated 
ROS in VSMCs stimulated with growth factors 
[23]. The extracellular-signal-regulated kinase 
(ERK)-MAPK proteins play a major role in cell 
proliferation and differentiation, as well as survival 
[33]. The ROS sensitivity of MAPK proteins has 
been subject to controversy, since some groups have 
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Figure 7. Aging and paracetamol treatment alters 
basal levels of apoptottc regulators BAX and Bcl2 in 
F344/N X BN rat aortae. Protein isolates from the aor-
tae excised from 6-month old and 33-month old control 
and 33-month old paracetamol-treated F344/N X BN 
rats were analyzed by immunoblotting for changes in 
BAX and Bcl-2 protein expression. Data are presented as 
means ± SE. Insets: representative blots for BAX and Bcl-
2. An asterisk (*) inaicates significant difference from 
the 6-month old control value, p < 0.05, (t) indicates 
significant difference from the 33-month old control 
value (P<O. 05). n = 8 in all groups. 
found these proteins to be sensitive [34, 35] while 
others have found them to be insensitive [36, 37]. 
In our present study, the amount of phosphorylated 
ERK1/2- and c-Jun N-terminal kinase (JNK) -
MAPK, but not p38, were lowered with age but 
increased with paracetamol treatment (Figure 6). 
The reason(s) for which paracetamol may increase 
the phosphorylation of MAPK proteins in the ag-
ing FBN aorta is currently not clear. Given that 
increases in MAPK phosphorylation have been im-
plicated in the initiation of cellular apoptosis, it is 
possible that the treatment-induced decreases in 
aortic wall thickness we observed may be related to 
increased levels of age-related VSMC apoptosis. 
The over-proliferation ofVSMCs has been posited 
to play a role in the development of several cardio-
vascular disorders. Reduced MAPK activity can 
lead to the down-regulation of the cyclin-depen-
dent kinase (cdk) inhibitor p21 which, in turn, can 
cause VSMC proliferation and hypertrophy [38]. 
Our data indicate that paracetamol may regulate 
cell proliferation by elevating ERK1/2 MAPK ac-
tivity. This up-regulation ofERK1/2 MAPK activ-
ity could potentially lead to an up-regulation of 
p21 and the inhibition of VSMC proliferation, 
thereby preventing vascular wall thickening. Future 
experiments designed to directly test this assertion 
will no doubt be useful in determining whether 
this mechanism actually exists. 
It is well established that increased aortic wall 
thickening can cause an increase in vessel stiffness, 
a primary risk factor for the development of hyper-
tension [24, 25]. To investigate the possibility that 
paracetamol diminishes age-associated aortic wall 
thickening by causing increased levels of apoptosis, 
we examined how paracetamol treatment affected 
the ratio of Bcl-2 to Bax. Bcl-2 is an evolutionary 
conserved protein that blocks apoptosis [39]. 
Conversely, Bax is a pro-apoptotic signaling pro-
tein of the Bcl-2 family that has been proposed to 
promote cell death by dimerizing anti-apoptotic 
proteins. It is thought that the susceptibility of a 
cell to apoptotic signals is regulated by the ratio of 
anti- to pro-apoptotic proteins [40, 41]. In the pres-
ent study, we observed that paracetamol treatment 
decreased the amount of Bcl-2, a finding which is 
consistent with an increase in VSMC apoptosis. 
Whether these changes are directly related to the 
decrease in aortic thickness seen with paracetamol 
treatment is currently unclear. 
In summary, our data indicate that paracetamol 
treatment decreases age-associated increases in aor-
tic wall thickening and protein oxidation. These 
changes were associated with alterations in AMPK 
and MAPK signaling and are consistent with the 
anti-oxidant properties of paracetamol. Further ex-
periments will be necessary to determine the exact 
mechanisms through which paracetamol may act 
to improve vascular health during aging. 
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